Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Completed(1)
Terminated(1)

Detailed Status

Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

withdrawn150%
completed150%

Recent Activity

0 active trials
Showing 2 of 2
withdrawnnot_applicable

Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic

NCT04416945
completednot_applicable

Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand

NCT05052502

Clinical Trials (2)

Showing 2 of 2 trials
NCT04416945Not Applicable

Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic

Withdrawn
NCT05052502Not Applicable

Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand

Completed

All 2 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
2